Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 2Phase 2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Keratosis, Actinic 4

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × OTHER × 3-ingenyl angelate × Clear all
NCT02866695 2022-03-09

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

University of California, San Francisco

Phase 4 Completed
20 enrolled 12 charts
Dermatologic

Keratosis, Actinic

NCT02990221 2019-09-24

Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy

University of Campania Luigi Vanvitelli

Phase 4 Completed
50 enrolled
Dermatologic

Keratosis, Actinic

NCT02281682 2017-10-30

Akti

Maastricht University Medical Center

Phase 4 Unknown
624 enrolled
Dermatologic

Keratosis, Actinic

NCT02251652 2017-04-26

Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses

Icahn School of Medicine at Mount Sinai

Phase 4 Completed
16 enrolled 5 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡